3D MEDICINES-B 01244 Prospectus Information

IPO Timeline

Broker Results (T-2)

2022-12-13

Some brokers release in afternoon

Grey Market (T-1)

2022-12-14

Afternoon

HKEX Allotment (T-1)

2022-12-14

Evening

Registrar Allotment (T-1)

2022-12-14

Evening

Listing Day (T)

2022-12-15

First day of trading

Company Overview

Stock Name	3D MEDICINES-B
Stock Code	01244
Company Full Name	3D MEDICINES-B
Industry	醫療保健
Principal Activities	主要於中國開發及商業化治療腫瘤產品及藥物。
Listing Date	2022-12-15
Listing Rules Era	Old Rules
Listing Rules Chapter	To be extracted
Weighted Voting Rights (WVR)	No
Registered Address (Mainland China)	中國上海市浦東新區芙蓉花路118號11號樓
Business Address (Hong Kong)	To be extracted
Place of Incorporation	To be extracted
Listing Method	To be extracted
Listing Board	Main Board
Website	https://www.3d-medicines.com/
Share Registrar	卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact	(852)2980 1333
A-Share/US Dual Listing	No data

Offering Information

Offering Mechanism	To be extracted
Offer Price	HK$ 24.98 / shares
Offer Price Range	To be extracted
Lot Size	To be extracted
Entry Threshold	To be extracted
Par Value	To be extracted
Offer Period	To be extracted
Global Offering Shares	To be extracted
HK Public Offer Shares (Initial)	To be extracted
Public Offer Lots (Initial)	To be extracted
International Placing Shares (Initial)	To be extracted
Offer Ratio	To be extracted
Total Shares Post-IPO	To be extracted
Greenshoe (Over-allotment Option)	To be confirmed
Stabilizing Manager (Greenshoe)	—
Cornerstone Share	57.4%
Clawback Tiers	To be extracted
Reallocation Option	To be confirmed
Total Global Offering Size	HK$ 40,842,300

Valuation & Financials

Market Cap (at Offer Price)	To be extracted
Pre-IPO Valuation (Last Round)	To be extracted
P/E Ratio	To be extracted
Profit/Loss Status	To be extracted
Period-End Cash Balance	To be extracted
Listing Expenses	To be extracted
Listing Expenses / Funds Raised	To be extracted
Total Pre-IPO Investment	To be extracted

First Day Performance

First Day Close	HK$ 31.45
First Day Open	HK$ 29.0
First Day Change	25.90%
First Day Volume	1515300.0
First Day Turnover	44431600.0

Use of Proceeds

Use of Proceeds	1、約55%，或138.1百萬港元，將用于公司的核心產品恩沃利單抗； 2、約25%，或62.8百萬港元，將用于公司的其他候選藥物； 3、約10%，或25.1百萬港元，將用于建造公司位于江蘇省徐州市的內部生產設施及采購新機器、儀器和設備； 4、約10%，或25.1百萬港元，將用于公司的一般企業及營運資金用途。

Underwriting Syndicate

Joint Sponsors (2)

中国国际金融香港证券有限公司 CE AEN894 中信建投（国际）融资有限公司 CE BAU112

Overall Coordinators (3)

中国国际金融香港证券有限公司 CE AEN894 中信建投（国际）融资有限公司 CE BAU112 信银（香港）资本有限公司 CE AEQ982

Joint Bookrunners (8)

Joint Lead Managers (13)

中国国际金融香港证券有限公司 CE AEN894 中信建投（国际）融资有限公司 CE BAU112 信银（香港）资本有限公司 CE AEQ982 建银国际金融有限公司 CE AJO225 华融国际证券有限公司利弗莫尔证券有限公司 CE BJN764 农银国际证券有限公司 CE ACX411 老虎证券（香港）环球有限公司 CE BMU940 SDHG International Securities Limited CE ADY241 力高证券有限公司 CE BIE918 华盛资本证券有限公司 CE AUL711 富途证券国际（香港）有限公司 CE AZT137 胜利证券有限公司 CE ABN091

Cornerstone Investors

#	Investor Name	Investment Amount	Shares Subscribed	% of Offer Shares	% of Total Shares	Lock-up Period	Est. Unlock Date
1	Harvest International Premium Value (Secondary Market) Fund SPC	78,449,690 HKD	—	19.21%	—	6 months	2023-06-15
2	Mobilewise Limited	31,374,880 HKD	—	7.68%	—	6 months	2023-06-15
3	好赞资产管理有限公司	78,449,690 HKD	—	19.21%	—	6 months	2023-06-15
4	徐州经济技术开发区(香港)投资有限公司	46,325,410 HKD	—	11.34%	—	6 months	2023-06-15

Directors & Management

Chairman	龔兆龍
Company Secretary	夏芳;李菁怡

No director data available.

Major Shareholders

Major Shareholders & Holdings	龔兆龍(29.08%);上海甄路企業管理諮詢合夥企業(有限合夥)(5.40%)

IPO Timeline

3D MEDICINES-B 01244Prospectus Information